Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Medicare’s hospital insurance fund will face shortfall by 2026

The latest report from Medicare trustees accelerated the timeline for the program’s hospital insurance fund being depleted to 2026—three years earlier than their previous report projected.

Wearables improve adherence in monitoring those with ischemic heart disease

Researchers from UCLA and Cedars Sinai Medical Center in Los Angeles have found activity trackers to be an effective remote monitoring tool for patients with ischemic heart disease (IHD), according to a study published in JAMIA.

Thumbnail

ED visits in California jump 9.9% after implementation of ACA

Proponents of the Affordable Care Act (ACA) argued—and continue to argue—that it will reduce frequent use of the emergency department (ED) by the same people with expanded coverage, especially for those most likely to make repeated visits to the ED.

Report: AI could save global healthcare $52B by 2021

The implementation of artificial intelligence (AI) applications in the global healthcare market is set to save the industry $52 billion by 2021, according to a report conducted by ABI Research.

Thumbnail

State Medicaid directors criticize new CMS scorecard

CMS has released a new a “scorecard” tracking quality measures of states within Medicaid and the Children’s Health Insurance Program (CHIP), but the National Association of Medicaid Directors (NAMD) said it failed to offer a true apples-to-apples comparison of state performance.

Thumbnail

Maine ordered by judge to expand Medicaid

Fifty-nine percent of Maine voters approved a ballot referendum last year to expand Medicaid eligibility in the state. After Republican Gov. Paul LePage repeatedly refused to implement it, a judge ruled Monday LePage's administration has to obey voters’ wishes and submit its expansion plan to CMS.

Rural community decides if it should trust outside investor with bankrupt hospital

Kaiser Health News reports on one facility—a 26-bed hospital in Surprise Valley, California—that is $4 million in debt—and in desperate need of outside help. The community may have found reason for hope, in the form of a 34-year-old former bodybuilder named Beau Gertz. He’s proposing a plan to use telemedicine to help boost revenue.

Thumbnail

ASCO 2018: FDA’s Gottlieb wants to streamline cancer patients’ access to treatments

FDA Commissioner Scott Gottlieb, MD, delivered the opening remarks at the American Society of Clinical Oncology’s 2018 annual meeting at McCormick Place in Chicago, emphasizing his organization’s goal of reducing the time needed to connect cancer patients with treatment.

Displaying 3481 - 3488 of 6654

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup